Gefapixant API (CAS No. 1015787-98-0) is a synthetic small-molecule pharmaceutical active ingredient associated with chronic cough and respiratory pharmaceutical development.
Gefapixant, also known by the development codes MK-7264 and AF-219, is a purinergic P2X3 receptor antagonist developed for the treatment of refractory or unexplained chronic cough.
P2X3 receptors are ATP-gated ion channels associated with sensory nerve signaling. Extracellular adenosine triphosphate can activate P2X3-containing receptors on sensory neurons and contribute to neuronal hypersensitivity and cough-reflex activation.
Gefapixant antagonizes P2X3 and P2X2/3 receptor activity. By reducing ATP-mediated sensory neuronal signaling, Gefapixant is associated with modulation of cough hypersensitivity and reduction of excessive cough-reflex activity.
Pharmaceutical companies sourcing Gefapixant API commonly evaluate assay, HPLC purity, chemical identity, related substances, process-related impurities, degradation products, residual solvents, water content, crystalline characteristics, particle size distribution, and batch-to-batch consistency.
Because Gefapixant is an achiral small molecule, chiral purity and specific optical rotation are not normally critical API release parameters. Instead, pharmaceutical buyers commonly focus on chromatographic purity, related substances, residual solvents, solid-state characteristics, and physical API consistency.
Gefapixant free compound and Gefapixant Citrate should be treated as separate pharmaceutical material identities. Procurement, quality, formulation, and regulatory teams should confirm the exact free compound or citrate form before commercial sourcing.
Swapnroop Drugs and Pharmaceuticals supplies Gefapixant API for qualified pharmaceutical research, chronic cough drug development, respiratory formulation development, analytical, and regulated manufacturing requirements with product-specific quality documentation, pharmaceutical-grade packaging, and reliable supply-chain coordination.
Swapnroop Drugs and Pharmaceuticals supports qualified pharmaceutical and respiratory drug-development customers with:
Gefapixant API is supplied in secure pharmaceutical-grade packaging selected according to product quantity, stability requirements, moisture protection requirements, and customer specifications.
Product-appropriate inner polyethylene liners and approved pharmaceutical-grade outer containers or HDPE drums may be used according to the supplied material specification.
Available packaging configurations may include:
Packaging configuration, MOQ, commercial quantity, particle size requirements, and shipment conditions are confirmed according to the approved product specification and customer enquiry.
Store Gefapixant API in tightly closed and appropriately labeled containers under recommended controlled storage conditions.
Protect the material from excessive moisture, heat, direct light, and unsuitable environmental exposure.
Handling should be performed by trained personnel using approved pharmaceutical raw material handling procedures and applicable safety documentation.
Product-specific storage and handling requirements should be confirmed from the approved COA, SDS, specification, and stability documentation.
Swapnroop Drugs and Pharmaceuticals provides Gefapixant API bulk supply and export support in India for qualified pharmaceutical manufacturers, chronic cough drug developers, respiratory formulation companies, analytical laboratories, research organizations, and pharmaceutical procurement customers.
For Gefapixant API price, CAS No. 1015787-98-0, HPLC purity, related substance profile, COA availability, MOQ, particle size requirements, packaging, and export enquiries, contact our pharmaceutical sales team.
Get Bulk Quote via WhatsApp